About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France

Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France

NCT05204342·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Montpellier

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

\- Diagnosic of Ovarian or Tubal Cancer C56 et C570
+/-
Carcinose péritonéale C786
Tumueur maligne secondaire de la plèvre C782,
Tumueur maligne secondaire des ganglions C770 à C779,
Tumueur maligne secondaire du foie C787,
Tumueur maligne secondaire du péritoine C786

You may not be if

autres causes de :
Carcinose péritonéale C786
Tumueur maligne secondaire de la plèvre C782,
Tumueur maligne secondaire des ganglions C770 à C779,
Tumueur maligne secondaire du foie C787,
Tumueur maligne secondaire du péritoine C786

The record

StatusCompleted

PhaseNo phase

Taking part22,500

StartedJan 2012

UpdatedJan 24, 2022

Conditions

Where1

Uhmontpellier
Montpellier, France